Brief: ISR Holdings Enters Collaboration With Beijing Kawin Technology Share-Holding

ISR Immune System Regulation Holding AB (publ)

09/09/2020 13:45

Sept 9 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * ISR HOLDINGS AB, ENTERS IMPORTANT COLLABORATION REGARDING
HEPATITIS B WITH BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO.,
LTD.
    * ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) - SIGNED A
MEMORANDUM OF UNDERSTANDING, WITH BEIJING KAWIN TECHNOLOGY
SHARE-HOLDING CO., LTD. (KAWIN), IN ORDER TO DEVELOP ISRS
IMMUNOLIDE ISR50 FOR HEPATITIS B (HBV)
    * ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) - TOGETHER
WITH
KAWIN, ISR WILL INITIATE PRE-CLINICAL TESTING IN ANIMAL MODELS
OF HBV EVALUATING IMMUNOSTIMULATORY PROPERTIES OF ISR50
    * ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) - OBJECTIVE
IS TO
EXPLORE, NEGOTIATE AND AGREE ON DETAILED AND DEFINITE TERMS OF
POTENTIAL LICENSE AGREEMENT BY 31(ST) OF MAY 2021

Source text for Eikon:  ID:nWkr5dkSPc 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))